Plain-English translation of NCT06244264 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using a patient's own blood (autologous transfusion) during spine surgery is safer and more effective than using donor blood (allogeneic transfusion) for people with lung cancer that has spread to the spine. The research team will monitor how many cancer cells appear in the blood after surgery and track whether new cancer spread occurs, along with measuring recovery and cost differences between the two approaches.
When spine surgery requires blood transfusion, doctors want to know if using a patient's own blood—rather than donor blood—might reduce the risk of cancer spread and other complications while keeping patients safe.
You likely qualify if…
You likely don't qualify if…
You will have open spine surgery to relieve pressure on your spinal cord and nerves. During surgery, if you need a blood transfusion, you will receive either your own blood (collected and filtered) or donor blood, depending on which group you are randomly assigned to. Before and after surgery, the research team will collect blood samples to count cancer cells and measure your recovery, with follow-up visits to track your healing and any new cancer spread.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
China